Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors.

Farrell PJ, Zopf CJ, Huang HJ, Balakrishna D, Holub C, Bilakovics J, Fanjul A, Matuszkiewicz J, Plonowski A, Rolzin P, Banerjee U, Ermolieff J, Cheruvallath ZS, McBride C, Bartkowski D, Mazur C, Pachori A, Larson CJ.

J Pharmacol Exp Ther. 2019 Nov;371(2):299-308. doi: 10.1124/jpet.119.259028. Epub 2019 Sep 19.

PMID:
31537613
2.

Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure".

Lanier M, Pickens J, Bigi SV, Bradshaw-Pierce EL, Chambers A, Cheruvallath ZS, Cole D, Dougan DR, Ermolieff J, Gibson T, Halkowycz P, Hirokawa A, Ivetac A, McBride C, Miura J, Nunez E, Sabat M, Tyhonas J, Wang H, Wang X, Swann S.

ACS Med Chem Lett. 2017 Nov 8;8(12):1341. doi: 10.1021/acsmedchemlett.7b00457. eCollection 2017 Dec 14.

3.

Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators.

Cheruvallath ZS, Gwaltney SL 2nd, Sabat M, Tang M, Wang H, Jennings A, Hosfield D, Lee B, Wu Y, Halkowycz P, Grimshaw CE.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2678-2682. doi: 10.1016/j.bmcl.2017.04.041. Epub 2017 Apr 13.

PMID:
28512030
4.

Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.

Lanier M, Pickens J, Bigi SV, Bradshaw-Pierce EL, Chambers A, Cheruvallath ZS, Cole D, Dougan DR, Ermolieff J, Gibson T, Halkowycz P, Hirokawa A, Ivetac A, Miura J, Nunez E, Sabat M, Tyhonas J, Wang H, Wang X, Swann S.

ACS Med Chem Lett. 2017 Feb 8;8(3):316-320. doi: 10.1021/acsmedchemlett.6b00481. eCollection 2017 Mar 9. Erratum in: ACS Med Chem Lett. 2017 Nov 08;8(12 ):1341.

5.

Design, synthesis and SAR of novel glucokinase activators.

Cheruvallath ZS, Gwaltney SL 2nd, Sabat M, Tang M, Feng J, Wang H, Miura J, Guntupalli P, Jennings A, Hosfield D, Lee B, Wu Y.

Bioorg Med Chem Lett. 2013 Apr 1;23(7):2166-71. doi: 10.1016/j.bmcl.2013.01.093. Epub 2013 Feb 4.

PMID:
23434031
6.

Solid phase synthesis of phosphorothioate oligonucleotides utilizing diethyldithiocarbonate disulfide (DDD) as an efficient sulfur transfer reagent.

Cheruvallath ZS, Kumar RK, Rentel C, Cole DL, Ravikumar VT.

Nucleosides Nucleotides Nucleic Acids. 2003 Apr;22(4):461-8.

PMID:
12885126
7.

A novel solid support for synthesis of oligonucleotide 3'-phosphorothioate monoesters.

Cheruvallath ZS, Cole DL, Ravikumar VT.

Bioorg Med Chem Lett. 2003 Jan 20;13(2):281-4.

PMID:
12482440
8.

Influence of diastereomeric ratios of deoxyribonucleoside phosphoramidites on the synthesis of phosphorothioate oligonucleotides.

Cheruvallath ZS, Sasmor H, Cole DL, Ravikumar VT.

Nucleosides Nucleotides Nucleic Acids. 2000 Mar;19(3):533-43.

PMID:
10843490
9.

Stability of phosphorothioate oligonucleotides in aqueous ammonia in presence of stainless steel.

Turney BJ, Cheruvallath ZS, Andrade M, Cole DL, Ravikumar VT.

Nucleosides Nucleotides. 1999 Jan;18(1):89-93.

PMID:
10048225
10.

Synthesis of biologically active taxol analogues with modified phenylisoserine side chains.

Georg GI, Cheruvallath ZS, Himes RH, Mejillano MR, Burke CT.

J Med Chem. 1992 Oct 30;35(22):4230-7.

PMID:
1359143

Supplemental Content

Loading ...
Support Center